Zofran Lawsuit Attorney​

More than 500 legal actions in federal court have stated that GlaxoSmithKline (GSK), the manufacturer of Zofran, knowingly advertised Zofran toward pregnant women despite the Food and Drug Administration (FDA) never approving the drug for this consumer group. Lawsuits allege that GSK hid evidence that showed the potential risks of using Zofran while pregnant and purposefully left consumers in the dark to turn a profit, allegedly promoting the drug as a means of treating morning sickness unlawfully and fraudulently.

GSK, like all medication manufacturers, owe the highest standards of care to consumers. It must thoroughly examine and test its drugs before selling them to the public. It must also obey all federal rules and regulations before marketing a new medication, including warning the public about known or foreseeable dangerous side effects. If GSK had tested Zofran and detected any signs of potential harm to consumers, it had a legal obligation to make these harms known. Unfortunately, a desire to make money from Zofran evidently led GSK to hide test results and falsely market the drug as safe.

Today, injured women and other parties are filing mass tort lawsuits against the manufacturer of Zofran for failing to detect safety risks, hiding dangerous side effects from the public, covering up animal studies that showed signs of toxicity, promoting the drug as safe for pregnant women, failing to evaluate safety information for use in treating morning sickness, fraudulently claiming it was safe for pregnant women, and producing a defective drug. The top complaint against Zofran is the risk of birth defects, along with claims that Zofran could cause a life-threatening heart condition in users. For additional information regarding filing a lawsuit for Zofran, speak with a New Jersey product liability attorney experienced in these types of claims.